About
We bring expertise, integrity, and innovation to research.
Our Facility
Who We Are

Dr. Junaid Syed, MD
Principal Investigator
Dr. Syed leads arch clinical trials with nearly 20 years of research experience and has participated in hundreds of phases II through IV clinical trials related to multiple CNS areas. Dr. Syed has graduated from Washington University in St. Louis and is a trailblazer in telehealth solutions. He is on the Board of Directors of the Department of Psychiatry at South City Hospital in St. Louis.
Dr. Syed also directs intensive outpatient programs at SSM Health St. Mary’s Hospital in St. Louis, MO; St. Luke’s Hospital in Trenton, MO; Red Bud Hospital in Red Bud, IL; Union County Hospital in Anna, IL; and Community Hospital in Fairfax, IL.

Kulsoom Junaid MD
Sub-Investigator
Dr. Kulsoom Junaid is a board-certified psychiatrist and dedicated Principal Investigator at Arch Clinical Trials, with over two decades of clinical and research experience. She specializes in psychiatry and has successfully led Phase I-IV clinical trials across various therapeutic areas, including treatments for schizophrenia, bipolar disorder, and dementia. Dr. Junaid is committed to advancing medical research while prioritizing patient care, protocol compliance, and the successful execution of clinical studies.

Jeff Davis, DNP, FNP-BC, PMHNP-BC, LNHA, CPHQ
VP, Operations
Jeffry Davis is a strategic, results-oriented Clinical Care Provider & Operations Executive with extensive experience in clinical operations oversight. As Vice President of Operations, he leads the management of various healthcare facilities, focusing on enhancing patient care and achieving key operational metrics. Jeff is dedicated to integrating clinical excellence with business growth strategies, ensuring alignment with organizational objectives and compliance with regulatory standards. His competencies include patient care, strategic planning, project management, and leadership in clinical settings.

Israa Diab MS
Senior Clinical Director
Israa Diab, MS, is the Senior Director of Clinical Research at Arch Clinical Trials, bringing over a decade of experience in clinical trial operations and regulatory compliance. With a Master’s in Science, she excels in leading teams to ensure adherence to GCP standards, driving high-quality research outcomes, and overseeing successful study execution. Her expertise lies in managing clinical trials with a focus on protocol adherence, quality assurance, and regulatory compliance.

Erica Ehrhardt
Clinical Research Coordinator

Ayeza Syed
Clinical Research Coordinator

Stephanie Rueda M.A.
Clinical Research Coordinator
Frequently Asked Questions
A clinical research study involves human participants in medical investigations that offer doctors and researchers deeper insights into specific diseases, aiding in the development of new treatments and medications. These studies are generally classified into two main types: observational and interventional. Observational studies seek to uncover the root causes of diseases or conditions, whereas interventional studies assess the effectiveness of new treatments, procedures, or lifestyle changes in curing or preventing diseases.
The eligibility criteria for clinical research study participation are determined by specific inclusion and exclusion guidelines. These criteria may include having specific medical conditions, falling within certain age groups, or having particular medical histories. These requirements are set to ensure that researchers collect pertinent data while prioritizing participant safety.
When you join a clinical research study, you contribute to scientific knowledge and potentially enhance global health outcomes. Beyond advancing science, these studies often encourage participants to adopt healthier lifestyles and become more engaged in their healthcare. Participants typically receive free medical care related to the study, and in interventional studies, they may access new treatments not yet available to the general public.
The duration of every research study varies widely. Some studies may last only a few weeks, while others can span several months or even years. Longer studies often provide more valuable and comprehensive information. Our aim is to ensure that participating in the study is as convenient as possible for all selected individuals.
Payment for clinical trials can vary based on factors such as the type and frequency of assessments conducted during each visit, the duration of the trial, and any additional study requirements. Participants usually receive stipends after completing each scheduled visit, and compensation for longer trials can range from hundreds to thousands of dollars in total.
We respect the personal and private nature of psychiatric assessments and treatments. Confidentiality in our clinical trials is rigorously upheld to safeguard participants’ privacy from external entities, and we are legally obligated to protect their confidentiality. This means we do not disclose participants’ information to employers or insurance companies. However, if pertinent to the study, we may need to gather details about your primary healthcare provider, always with the participant’s signed consent beforehand.
Arch Clinical Trials has its own building for inpatient studies, located at 1400 Lemay Ferry Road. Only subjects participating in inpatient trials will be staying at this center.